The most effective way to prevent further confusion between Topamax and Toprol-XL–the brand names of topiramate and metoprolol succinate–would be to change one of their names, according to Michael …
Simone Roberts
The PBS listing of Topamax on 1 December has marked the first subsidy for a migraine prophylactic in 10 years.
TOPAMAX (topiramate 25/50mg tablets) is now available for adults who suffer an average of three or more migraines per month over a period of at least six m…
The Food and Drug Administration has approved Topamax as an initial monotherapy for epilepsy in patients age …
Related Results
Ortho-McNeil, J&J step up the fight against dispensing errors.(OrthoMcNei…
…
* Johnson & Johnson officials discussed new indications for Topamax (topiramate), during a conference call on the company’s second quarter 2003 earnings. Topamax is a widely prescribed drug with indications for seizure disorders and bipolar disorder. With its recent launch of Axert for migraine headaches, the company is entering the migraine market, but its bigger plans are for Topamax as a preventive therapy for migraines.
…
The Food and Drug Administration has approved a new indication for the anti-epileptic drug, Topamax (topiramate) Tablets, as an add-on treatment for pediatric patients ages 2 to 16 who experience part…
“Chemically, Topamax is Topiramate, which is an anticonvulsant, with a chemical formula of C12H21NO8S. Topamax is used for controlling seizures in adults and children with various kinds of epilepsy. Topamax is also prescr…
* Johnson & Johnson’s popular epilepsy drug Topamax (topiramate) is showing promise as a treatment for migraine headaches. The company announced it will seek additional FDA approval for Topamax to be used as a preventive therapy for migraines. Topamax is currently approved to treat epileptic seizures as an adjunctive therapy, and the company is seeking further FDA approval for the drug to be used as a monotherapy for epilepsy.
Most Popular
10 Jobs …
Topiramate appears to help alleviate the weight gain associated with olanzapine use in women, reported Marius K. Nickel, M.D., of Inntalk linik in Simbach/Inn, Germany, and associates.
In a 10-week trial of women on olanzapine (Zyprexa) for 3 months or more who had gained at least 5 kg since beginning treatment, 25 women were randomized to topiramate (Topamax) and 18 to placebo. Every 2 weeks the subjects were interviewed and weighed.
…
